Too dilute, and you are underdosing
Orforglipron represents a true leap forward
As a new pill form of the weight loss drug hits the market, we are with one of the patients who took part in the Wegovy pill clinical trial
Were excited to find ways to continue bringing branded treatments to the platform across specialties
(7) Following the absorption of food, GLP-1 and GIP promote insulin secretion, otherwise known as the incretin effect
The main results of the trial were as follows: Patients taking the maximum dose (12mg) lost an average of 70.3 lbs (28.3%) over 80 weeks Participants with a baseline body mass index (BMI) of 35 or above lost an average of 85 lbs (30.3%) over 104 weeks 45.3% of patients taking the maximum 12 mg dose lost 30% or more of their starting body weight a result normally seen after weight loss (bariatric) surgery The study also found significant improvements in key markers for metabolic syndrome, such as waist circumference, blood pressure, and harmful blood fats such as triglycerides and non-HDL cholesterol How does retatrutide compare to other weight loss medications
